CLINICAL_TRIALS
trial_result
· 2024-01-10
Clinical Trial Update: Intravenous Thyroxine for Heart-Eligible Organ Donors [Phase 3]
Summary
Phase 3 clinical trial evaluating intravenous thyroxine for heart-eligible organ donors has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Brain Death, Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2024-01-10